Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine

Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient is very infrequent and this case highlights how it can be associated to other types of immunosuppression. Moreover, this case reports an effective therapeutic option with miltefosine, which can be very useful d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of travel medicine 2022-11, Vol.29 (7)
Hauptverfasser: Monge-Maillo, Begoña, Norman, Francesca F, Chamorro-Tojeiro, Sandra, Gioia, Francesca, Pérez-Molina, José-Antonio, Chicharro, Carmen, Moreno, Javier, López-Vélez, Rogelio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page
container_title Journal of travel medicine
container_volume 29
creator Monge-Maillo, Begoña
Norman, Francesca F
Chamorro-Tojeiro, Sandra
Gioia, Francesca
Pérez-Molina, José-Antonio
Chicharro, Carmen
Moreno, Javier
López-Vélez, Rogelio
description Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient is very infrequent and this case highlights how it can be associated to other types of immunosuppression. Moreover, this case reports an effective therapeutic option with miltefosine, which can be very useful due to the scarce experience reported.
doi_str_mv 10.1093/jtm/taab169
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2584016995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jtm/taab169</oup_id><sourcerecordid>2823856032</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-630a3914bd82e94f620b674819703d1d376d3e26fe7e2f05695ad0fef9f405163</originalsourceid><addsrcrecordid>eNp9kUtrHDEQhEVIiF855R4EgWAIY-sx0khHY5LYsGAfHF-H3lUr1npGs5Y0MfGvt8JufMjBpy6aj6KoIuQjZyecWXm6LuNpAVhybd-Qfd4x0xjJ1NuquVUNt0bskYOc14wxYYR4T_Zkq7VRyuyTdD3l0tzDAA08QaIO0wgDHTDkuxFigBwydTPSMtHFy5OG6CGWeayCQqQXl7dNxF9Qwm-km3owFloSQkFHH0O5o2MYCvoph4hH5J2HIeOH3T0kP79_uzm_aBZXPy7PzxbNShpVGi0ZSMvbpTMCbeu1YEvdtYbbjknHney0kyi0xw6FZ0pbBY559Na3THEtD8nx1neTpocZc-nHkFc4DBBxmnMvlGlZLc2qin7-D11Pc4o1XV8bq3E0k6JSX7fUKk05J_T9JoUR0p-es_7vFH2dot9NUelPO895OaJ7Yf91X4EvW2CaN686PQPLwJKx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2823856032</pqid></control><display><type>article</type><title>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Monge-Maillo, Begoña ; Norman, Francesca F ; Chamorro-Tojeiro, Sandra ; Gioia, Francesca ; Pérez-Molina, José-Antonio ; Chicharro, Carmen ; Moreno, Javier ; López-Vélez, Rogelio</creator><creatorcontrib>Monge-Maillo, Begoña ; Norman, Francesca F ; Chamorro-Tojeiro, Sandra ; Gioia, Francesca ; Pérez-Molina, José-Antonio ; Chicharro, Carmen ; Moreno, Javier ; López-Vélez, Rogelio</creatorcontrib><description>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient is very infrequent and this case highlights how it can be associated to other types of immunosuppression. Moreover, this case reports an effective therapeutic option with miltefosine, which can be very useful due to the scarce experience reported.</description><identifier>ISSN: 1195-1982</identifier><identifier>EISSN: 1708-8305</identifier><identifier>DOI: 10.1093/jtm/taab169</identifier><identifier>PMID: 34668558</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Antifungal agents ; Antiprotozoal Agents - therapeutic use ; Case reports ; Diabetes ; HIV ; HIV Infections - complications ; HIV Infections - drug therapy ; Human immunodeficiency virus ; Humans ; Immunosuppression ; Leishmania infantum ; Leishmaniasis ; Leishmaniasis, Cutaneous - diagnosis ; Leishmaniasis, Cutaneous - drug therapy ; Leishmaniasis, Visceral - diagnosis ; Leishmaniasis, Visceral - drug therapy ; Miltefosine ; Phosphorylcholine - therapeutic use ; Vector-borne diseases</subject><ispartof>Journal of travel medicine, 2022-11, Vol.29 (7)</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of International Society of Travel Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2021</rights><rights>The Author(s) 2021. Published by Oxford University Press on behalf of International Society of Travel Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-630a3914bd82e94f620b674819703d1d376d3e26fe7e2f05695ad0fef9f405163</citedby><cites>FETCH-LOGICAL-c385t-630a3914bd82e94f620b674819703d1d376d3e26fe7e2f05695ad0fef9f405163</cites><orcidid>0000-0003-0960-1630 ; 0000-0003-0336-7767</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34668558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Monge-Maillo, Begoña</creatorcontrib><creatorcontrib>Norman, Francesca F</creatorcontrib><creatorcontrib>Chamorro-Tojeiro, Sandra</creatorcontrib><creatorcontrib>Gioia, Francesca</creatorcontrib><creatorcontrib>Pérez-Molina, José-Antonio</creatorcontrib><creatorcontrib>Chicharro, Carmen</creatorcontrib><creatorcontrib>Moreno, Javier</creatorcontrib><creatorcontrib>López-Vélez, Rogelio</creatorcontrib><title>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine</title><title>Journal of travel medicine</title><addtitle>J Travel Med</addtitle><description>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient is very infrequent and this case highlights how it can be associated to other types of immunosuppression. Moreover, this case reports an effective therapeutic option with miltefosine, which can be very useful due to the scarce experience reported.</description><subject>Antifungal agents</subject><subject>Antiprotozoal Agents - therapeutic use</subject><subject>Case reports</subject><subject>Diabetes</subject><subject>HIV</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immunosuppression</subject><subject>Leishmania infantum</subject><subject>Leishmaniasis</subject><subject>Leishmaniasis, Cutaneous - diagnosis</subject><subject>Leishmaniasis, Cutaneous - drug therapy</subject><subject>Leishmaniasis, Visceral - diagnosis</subject><subject>Leishmaniasis, Visceral - drug therapy</subject><subject>Miltefosine</subject><subject>Phosphorylcholine - therapeutic use</subject><subject>Vector-borne diseases</subject><issn>1195-1982</issn><issn>1708-8305</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtrHDEQhEVIiF855R4EgWAIY-sx0khHY5LYsGAfHF-H3lUr1npGs5Y0MfGvt8JufMjBpy6aj6KoIuQjZyecWXm6LuNpAVhybd-Qfd4x0xjJ1NuquVUNt0bskYOc14wxYYR4T_Zkq7VRyuyTdD3l0tzDAA08QaIO0wgDHTDkuxFigBwydTPSMtHFy5OG6CGWeayCQqQXl7dNxF9Qwm-km3owFloSQkFHH0O5o2MYCvoph4hH5J2HIeOH3T0kP79_uzm_aBZXPy7PzxbNShpVGi0ZSMvbpTMCbeu1YEvdtYbbjknHney0kyi0xw6FZ0pbBY559Na3THEtD8nx1neTpocZc-nHkFc4DBBxmnMvlGlZLc2qin7-D11Pc4o1XV8bq3E0k6JSX7fUKk05J_T9JoUR0p-es_7vFH2dot9NUelPO895OaJ7Yf91X4EvW2CaN686PQPLwJKx</recordid><startdate>20221104</startdate><enddate>20221104</enddate><creator>Monge-Maillo, Begoña</creator><creator>Norman, Francesca F</creator><creator>Chamorro-Tojeiro, Sandra</creator><creator>Gioia, Francesca</creator><creator>Pérez-Molina, José-Antonio</creator><creator>Chicharro, Carmen</creator><creator>Moreno, Javier</creator><creator>López-Vélez, Rogelio</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M3G</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0960-1630</orcidid><orcidid>https://orcid.org/0000-0003-0336-7767</orcidid></search><sort><creationdate>20221104</creationdate><title>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine</title><author>Monge-Maillo, Begoña ; Norman, Francesca F ; Chamorro-Tojeiro, Sandra ; Gioia, Francesca ; Pérez-Molina, José-Antonio ; Chicharro, Carmen ; Moreno, Javier ; López-Vélez, Rogelio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-630a3914bd82e94f620b674819703d1d376d3e26fe7e2f05695ad0fef9f405163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antifungal agents</topic><topic>Antiprotozoal Agents - therapeutic use</topic><topic>Case reports</topic><topic>Diabetes</topic><topic>HIV</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immunosuppression</topic><topic>Leishmania infantum</topic><topic>Leishmaniasis</topic><topic>Leishmaniasis, Cutaneous - diagnosis</topic><topic>Leishmaniasis, Cutaneous - drug therapy</topic><topic>Leishmaniasis, Visceral - diagnosis</topic><topic>Leishmaniasis, Visceral - drug therapy</topic><topic>Miltefosine</topic><topic>Phosphorylcholine - therapeutic use</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Monge-Maillo, Begoña</creatorcontrib><creatorcontrib>Norman, Francesca F</creatorcontrib><creatorcontrib>Chamorro-Tojeiro, Sandra</creatorcontrib><creatorcontrib>Gioia, Francesca</creatorcontrib><creatorcontrib>Pérez-Molina, José-Antonio</creatorcontrib><creatorcontrib>Chicharro, Carmen</creatorcontrib><creatorcontrib>Moreno, Javier</creatorcontrib><creatorcontrib>López-Vélez, Rogelio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business &amp; Current Affairs Database</collection><collection>Canadian Business &amp; Current Affairs Database (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>CBCA Reference &amp; Current Events</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of travel medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Monge-Maillo, Begoña</au><au>Norman, Francesca F</au><au>Chamorro-Tojeiro, Sandra</au><au>Gioia, Francesca</au><au>Pérez-Molina, José-Antonio</au><au>Chicharro, Carmen</au><au>Moreno, Javier</au><au>López-Vélez, Rogelio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine</atitle><jtitle>Journal of travel medicine</jtitle><addtitle>J Travel Med</addtitle><date>2022-11-04</date><risdate>2022</risdate><volume>29</volume><issue>7</issue><issn>1195-1982</issn><eissn>1708-8305</eissn><abstract>Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient is very infrequent and this case highlights how it can be associated to other types of immunosuppression. Moreover, this case reports an effective therapeutic option with miltefosine, which can be very useful due to the scarce experience reported.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>34668558</pmid><doi>10.1093/jtm/taab169</doi><orcidid>https://orcid.org/0000-0003-0960-1630</orcidid><orcidid>https://orcid.org/0000-0003-0336-7767</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1195-1982
ispartof Journal of travel medicine, 2022-11, Vol.29 (7)
issn 1195-1982
1708-8305
language eng
recordid cdi_proquest_miscellaneous_2584016995
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Alma/SFX Local Collection
subjects Antifungal agents
Antiprotozoal Agents - therapeutic use
Case reports
Diabetes
HIV
HIV Infections - complications
HIV Infections - drug therapy
Human immunodeficiency virus
Humans
Immunosuppression
Leishmania infantum
Leishmaniasis
Leishmaniasis, Cutaneous - diagnosis
Leishmaniasis, Cutaneous - drug therapy
Leishmaniasis, Visceral - diagnosis
Leishmaniasis, Visceral - drug therapy
Miltefosine
Phosphorylcholine - therapeutic use
Vector-borne diseases
title Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T16%3A22%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Post-kala-azar%20dermal%20leishmaniasis%20due%20to%20Leishmania%20infantum%20in%20an%20HIV-negative%20patient%20treated%20with%20miltefosine&rft.jtitle=Journal%20of%20travel%20medicine&rft.au=Monge-Maillo,%20Bego%C3%B1a&rft.date=2022-11-04&rft.volume=29&rft.issue=7&rft.issn=1195-1982&rft.eissn=1708-8305&rft_id=info:doi/10.1093/jtm/taab169&rft_dat=%3Cproquest_cross%3E2823856032%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2823856032&rft_id=info:pmid/34668558&rft_oup_id=10.1093/jtm/taab169&rfr_iscdi=true